NYSE:ELMD Electromed (ELMD) Stock Price, News & Analysis $23.58 -0.57 (-2.36%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$23.25 -0.33 (-1.40%) As of 08:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Electromed Stock (NYSE:ELMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Electromed alerts:Sign Up Key Stats Today's Range$23.01▼$23.8050-Day Range$23.34▼$35.4352-Week Range$13.74▼$35.56Volume71,588 shsAverage Volume66,842 shsMarket Capitalization$201.77 millionP/E Ratio31.44Dividend YieldN/APrice Target$38.00Consensus RatingStrong Buy Company OverviewElectromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Read More… Remove Ads Electromed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreELMD MarketRank™: Electromed scored higher than 19% of companies evaluated by MarketBeat, and ranked 818th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageElectromed has only been the subject of 1 research reports in the past 90 days.Read more about Electromed's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 31.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.68.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 31.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.22.Price to Book Value per Share RatioElectromed has a P/B Ratio of 4.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ELMD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ELMD. News and Social Media2.6 / 5News SentimentN/A News SentimentElectromed has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Electromed this week, compared to 1 article on an average week.Search Interest8 people have searched for ELMD on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Electromed to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,821,636.00 in company stock.Percentage Held by Insiders14.00% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Electromed's insider trading history. Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Email Address ELMD Stock News HeadlinesElectromed Announces Share Repurchase Authorization - Quick FactsMarch 12, 2025 | nasdaq.comElectromed announces $5M share repurchase authorizationMarch 10, 2025 | markets.businessinsider.comCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…April 4, 2025 | Investors Alley (Ad)Electromed management to meet with Lake StreetMarch 4, 2025 | msn.comElectromed Inc. to Participate in Upcoming Investor ConferencesFebruary 26, 2025 | finance.yahoo.comElectromed Inc. to Participate in Upcoming Investor ConferencesFebruary 26, 2025 | businesswire.comElectromed director Kathleen Skarvan sells shares worth $2.33 millionFebruary 22, 2025 | investing.comB. Riley Securities Initiates Coverage of Electromed (ELMD) with Buy RecommendationFebruary 21, 2025 | msn.comSee More Headlines ELMD Stock Analysis - Frequently Asked Questions How have ELMD shares performed this year? Electromed's stock was trading at $29.55 on January 1st, 2025. Since then, ELMD shares have decreased by 20.2% and is now trading at $23.58. View the best growth stocks for 2025 here. How were Electromed's earnings last quarter? Electromed, Inc. (NYSE:ELMD) released its quarterly earnings results on Tuesday, November, 12th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.13. The business earned $14.67 million during the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%. How will Electromed's stock buyback program work? Electromed's Board of Directors authorized a stock buyback program on Monday, March 10th 2025, which allows the company to buy back $5,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 2.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its stock is undervalued. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/12/2024Today4/04/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNYSE:ELMD CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees160Year FoundedN/APrice Target and Rating Average Stock Price Target$38.00 High Stock Price Target$38.00 Low Stock Price Target$38.00 Potential Upside/Downside+61.2%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.75 Trailing P/E Ratio31.44 Forward P/E RatioN/A P/E GrowthN/ANet Income$5.15 million Net Margins11.34% Pretax Margin15.57% Return on Equity15.71% Return on Assets13.37% Debt Debt-to-Equity RatioN/A Current Ratio5.10 Quick Ratio4.74 Sales & Book Value Annual Sales$59.63 million Price / Sales3.38 Cash Flow$0.57 per share Price / Cash Flow41.36 Book Value$5.10 per share Price / Book4.62Miscellaneous Outstanding Shares8,557,000Free Float7,359,000Market Cap$201.77 million OptionableOptionable Beta0.41 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NYSE:ELMD) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
